Receiving and storing COVID-19 Vaccine Moderna at PCN designated Sites

Sue Dickinson, Director of Pharmacy, Regional Drug & Therapeutics Centre (Newcastle)Published Last updated See all updates

Standard Operating Procedure for PCN designated sites receiving and storing the Moderna Spikevax® COVID-19 Vaccine


A standard operating procedure  is attached to this page

Your should also familiarise yourself with our background guide Facilitating Pharmaceutical support to PCN Designated Sites for COVID-19 vaccinations before using this SOP.

These documents may be adapted by Superintendent Pharmacists for the use of the vaccine in community pharmacy settings


Other handling content for PCNs

Other COVID-19 vaccines resources

What to do if you still have questions

If you still have questions you can get in touch with us. However, please first read our service remit; and if you still think we can help, use the email address below.

We're supporting healthcare professionals in England with pharmaceutical aspects of the COVID-19 vaccination programme; read our service remit to find out more.
If you're a healthcare professional who needs further advice, get in touch with us. We answer questions about Medicines Optimisation issues, including those about the COVID-19 vaccination programme. Help us to help you: tell us where on our site you were.

Change history

  1. Section 4.2 addition to clarify wholesaler responsibility regarding transit time greater than 6 hours to delivery
  1. Current content remains accurate
  1. Current content still accurate
  1. The name of the vaccine has changed to Spikevax®
  1. Reworked to reflect the fact that PCNs will receive thawed Moderna COVID-19 vaccine
  1. Published